The 3D Printing technology is an additive manufacturing process where biomaterials are used for various tissue engineering applications. Various materials are used for developing implants and constructs depending upon the tissue engineering applications. Metallic, Ceramic, Polymeric, Composite, Nanomaterials as well as Smart Biomaterials (4D printing applications) are used in this technology. This technology is very simple and cost-effective for the production of biomedical implants and degradable scaffolds for various tissue engineering applications. This technology is also used in drug discovery, artificial organs, microfluidic devices drug delivery etc. The organization of this collection will provide a detailed overview and the recent advancements of this technology for biomedical applications and will mention aspects such as: the various materials used in this technology, various 3D printing technologies which are suitable for the respective biomaterials, biomaterials fabrications; the recent advancement of this technology in for drug design, drug delivery; the importance of this technology in various tissue engineering applications like skin, bone, cartilage, artificial organs; the recent advancement of this technology in microfluidic devices; the application of 4D printing technology its recent advances in biomedical engineering applications. This Research Topic will introduce the concept of 3D printing technology in biomedical applications in detail for the scientific and technological communities.
3D printing technology is a benefit for biomedical engineers and scientists. Researchers all around the world are working on this technology to rectify various limitations. Though this technology is very old, lots of unknown areas are still unexplored and need to be addressed. The limitations of 3D printing and bioprinting technology are listed below:
1. Limited Materials
2. Restricted Build Size
3. Post Processing
4. Large Volumes
5. Part Structure
6. Reduction in Manufacturing Jobs
7. Design Inaccuracies
8. Copyright Issues
Additionally, further limitations of 3D bioprinting must be addressed:
-Questions of liability if a printed object fails.
-Disputed ownership of the codes and implants produced.
-Various ethical concerns.
-Pricing; availability to only the wealthy.
-Difficulty in maintaining cell environment, resulting in the death of many cells.
-Development of fully functional organs is still not possible.
These limitations will be discussed and covered in this collection. All the recent developments that are done for rectifying these limitations will be covered in this collection as much as possible.
The type of manuscripts which are suitable for this section are listed below:
a) Metallic, ceramic, polymeric, composite, smart materials, and nanomaterials used by 3D printing for biomedical and tissue engineering applications.
b) Advancements in drug delivery and drug design by this technology.
c) The connection between microfluidic devices (Lab-on-a-chip) and bioprinting technology for biomimetic microenvironment with a heterogeneous 3D structure.
d) Recent advancements of this technology in various tissue engineering applications like skin, bone, cartilage, artificial organs etc.
e) 4D printing recent advancements in biomedical applications.
The 3D Printing technology is an additive manufacturing process where biomaterials are used for various tissue engineering applications. Various materials are used for developing implants and constructs depending upon the tissue engineering applications. Metallic, Ceramic, Polymeric, Composite, Nanomaterials as well as Smart Biomaterials (4D printing applications) are used in this technology. This technology is very simple and cost-effective for the production of biomedical implants and degradable scaffolds for various tissue engineering applications. This technology is also used in drug discovery, artificial organs, microfluidic devices drug delivery etc. The organization of this collection will provide a detailed overview and the recent advancements of this technology for biomedical applications and will mention aspects such as: the various materials used in this technology, various 3D printing technologies which are suitable for the respective biomaterials, biomaterials fabrications; the recent advancement of this technology in for drug design, drug delivery; the importance of this technology in various tissue engineering applications like skin, bone, cartilage, artificial organs; the recent advancement of this technology in microfluidic devices; the application of 4D printing technology its recent advances in biomedical engineering applications. This Research Topic will introduce the concept of 3D printing technology in biomedical applications in detail for the scientific and technological communities.
3D printing technology is a benefit for biomedical engineers and scientists. Researchers all around the world are working on this technology to rectify various limitations. Though this technology is very old, lots of unknown areas are still unexplored and need to be addressed. The limitations of 3D printing and bioprinting technology are listed below:
1. Limited Materials
2. Restricted Build Size
3. Post Processing
4. Large Volumes
5. Part Structure
6. Reduction in Manufacturing Jobs
7. Design Inaccuracies
8. Copyright Issues
Additionally, further limitations of 3D bioprinting must be addressed:
-Questions of liability if a printed object fails.
-Disputed ownership of the codes and implants produced.
-Various ethical concerns.
-Pricing; availability to only the wealthy.
-Difficulty in maintaining cell environment, resulting in the death of many cells.
-Development of fully functional organs is still not possible.
These limitations will be discussed and covered in this collection. All the recent developments that are done for rectifying these limitations will be covered in this collection as much as possible.
The type of manuscripts which are suitable for this section are listed below:
a) Metallic, ceramic, polymeric, composite, smart materials, and nanomaterials used by 3D printing for biomedical and tissue engineering applications.
b) Advancements in drug delivery and drug design by this technology.
c) The connection between microfluidic devices (Lab-on-a-chip) and bioprinting technology for biomimetic microenvironment with a heterogeneous 3D structure.
d) Recent advancements of this technology in various tissue engineering applications like skin, bone, cartilage, artificial organs etc.
e) 4D printing recent advancements in biomedical applications.